Related Experiment Video

Updated: Jul 23, 2025

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure
07:41

Echocardiographic Evaluation of Atrial Communications before Transcatheter Closure

Published on: February 8, 2022

3.7K

Risk Factors, Management, and Avoidance of Conduction System Disease after Transcatheter Aortic Valve Replacement

Mohamad S Alabdaljabar1, Mackram F Eleid2

  • 1Department of Internal Medicine, Mayo Clinic, Rochester, MN 55905, USA.

Journal of Clinical Medicine
|July 14, 2023
PubMed

Insights

Transcatheter aortic valve replacement (TAVR) can lead to conduction disease, a frequent complication. Understanding patient and procedural risk factors is key to preventing and managing this condition effectively.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Medical Device Technology

Background:

  • Transcatheter aortic valve replacement (TAVR) is a key treatment for aortic stenosis (AS).
  • Conduction disease is a common and serious complication following TAVR.
  • Identifying risk factors is crucial for managing post-TAVR conduction disease.

Purpose of the Study:

  • To review the incidence and risk factors of TAVR-associated conduction disease.
  • To discuss current management strategies for conduction disease post-TAVR.
  • To highlight the need for better risk stratification and prevention.

Main Methods:

  • Literature review of studies on TAVR and conduction disease.
  • Analysis of patient-related risk factors (AS severity, calcification, pre-existing conditions).
  • Evaluation of procedure-related risk factors (valve type, implantation depth, ratios, technique).

Main Results:

  • Conduction disease incidence and risk factors are multifactorial.
  • Patient factors include AS severity, valve calcification, and prior conduction issues.
  • Procedural factors involve valve choice, implantation depth, and technique.

Conclusions:

  • Risk stratification for conduction disease post-TAVR requires comprehensive evaluation.
  • Current management approaches vary and are often based on expert opinion.
  • Further research is needed to standardize prevention and treatment protocols.

Keywords:
aortic valve stenosisconduction diseaseheart blockmanagementtranscatheter aortic valve replacement

More Related Videos

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement08:50

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

Published on: March 26, 2018

11.7K
Implantation of the Syncardia Total Artificial Heart16:11

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

35.3K

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
26
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
13
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
23
Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
18
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
15
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
22